Russell Investments Group’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Russell Investments Group's ATRC Position: Q2 2026 in Review
Russell Investments Group increased its AtriCure (ATRC) stake by 43% in Q2 2026, buying an estimated $185K and bringing the position to 21,908 shares worth $613K. The position accounts for ﹤0.01% of the portfolio, ranked #2685.
Russell Investments Group first reported a position in ATRC in Q3 2019 and has held it in 19 quarters since. The position peaked at $5.86M in Q1 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Russell Investments Group held 21,908 shares of AtriCure worth $613K as of Q2 2026.
- Russell Investments Group bought 6,574 AtriCure shares in Q2 2026, an estimated $185K.
- AtriCure made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2685 holding.
- Russell Investments Group first reported a position in AtriCure in Q3 2019 and has held it in 19 quarters since.
- Russell Investments Group's AtriCure position peaked at $5.86M in Q1 2025.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.